{"url_path":"/sec/kalv/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1348911/0001193125-26-223976-index.html","accession_number":"0001193125-26-223976","cik":"0001348911","ticker":"KALV","issuer_name":"KalVista Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1348911/0001193125-26-223976-index.html","primary_entity_key":"0001348911","primary_entity_name":"KalVista Pharmaceuticals, Inc."},"word_count":29,"has_tables":true,"body_markdown":"Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS\n\nSales of Unregistered Securities\n\nNot applicable.\n\nUse of Proceeds\n\nNot applicable.\n\nIssuer Purchases of Equity Securities\n\nNot applicable."}